Intuitive Surgical stock trades around $372 as investors digest recent performance
Published on 08/31/2026 at 07:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intuitive Surgical Inc. (US46120E6023) stock is quoted at $372.60 on Nasdaq as of August 30, 2026, leaving the shares well off their 52-week high even after a modest rebound from a prior close of $367.07.
Recent price action and valuation context
Market data compiled on August 30, 2026 show Intuitive Surgical stock closing the latest regular session at $372.60, up from $367.07 in the preceding session, with the day’s trading range spanning $366.74 to $373.40. The same dataset points to a 52-week range between $328.57 at the low end and $603.88 at the high, underlining how far the current quote sits below the peak despite the recent lift from the mid-$360s.
For investors, that profile combines a moderate short-term recovery with a sizable gap to the historical high, suggesting that sentiment has cooled after a stronger phase earlier in the year. The relatively tight daily range around the high-$360s to low-$370s also indicates that the stock is consolidating rather than making a decisive move in either direction at the moment.
Fundamentals and cash flow trends
Recent coverage of Intuitive Surgical highlights strong cash flow dynamics, with commentary indicating that operating cash flow jumped 71 percent in a recent reporting period compared with the prior year. While the exact quarter is not specified in the short excerpts available, the emphasis on a two-digit percentage increase in cash generation underscores that the company has been converting its robotics-driven revenue into significantly higher cash inflows.
The same discussion notes that the shares ended a recent trading session at EUR 321.40 in a European listing, representing a 2.0 percent increase for that day but a 34 percent decline year-to-date. That combination of stronger cash flow and a steep year-to-date share price drop offers a quantified comparison between fundamentals and market performance, illustrating that the stock has lagged materially even as underlying cash metrics improved.
Analyst commentary referenced in the same context points out differing views on Intuitive Surgical’s valuation, with one research house citing a price objective of $500 while another shifted its stance toward a more neutral rating. Those figures frame a corridor between the current $372.60 spot price and an aspirational $500 target, highlighting the debate over how much of the company’s growth and cash flow strength is already reflected in the share price.
Robotic surgery platform as a growth engine
Intuitive Surgical’s business is anchored by its da Vinci robotic surgery systems, which are installed in hospitals worldwide to support minimally invasive procedures in areas such as urology, gynecology, and general surgery. Revenue comes from several streams, including the sale of new systems, ongoing instrument and accessory usage linked to procedure volumes, and service contracts, creating a recurring component that ties directly to how frequently surgeons use the platform.
Historically, procedure growth has been a key driver for the company, as higher case volumes translate into greater demand for disposable instruments and accessories. That recurring usage, combined with service agreements, tends to support relatively stable cash flows across economic cycles, which aligns with the reported 71 percent surge in operating cash flow highlighted in recent commentary as a sign that the model continues to scale.
Closing view on Intuitive Surgical stock
As of August 30, 2026, Intuitive Surgical stock trades at $372.60 on Nasdaq, measured against a 52-week high of $603.88 and a recent analyst price objective of $500, giving investors a concrete sense of where the current quote sits in relation to both historical peaks and selected forward-looking valuation benchmarks.
Fact box
Company: Intuitive Surgical Inc.
ISIN: US46120E6023
Ticker: ISRG
Exchange: Nasdaq
Price (as of August 30, 2026, close): $372.60 USD
Market cap: not stated in the available excerpts
Sector / Industry: Health care / Medical devices and robotics
Index membership: S&P 500
